ArticleBMJ open2011

Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial.

Eduardo Vilar Gomez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.